TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer's Disease

Translational Stroke Research

Volumn 3, Issue SUPPL. 1, 2012, Pages 102-112

  Valant, Valerie ^a,b   Keenan, Brendan T ^b,c   Anderson, Christopher D ^a,b   Shulman, Joshua M ^b,c   Devan, William J ^a,b   Ayres, Alison M ^a   Schwab, Kristin ^a   Goldstein, Joshua N ^a   Viswanathan, Anand ^a   Greenberg, Steven M ^a   Bennett, David A ^d   de Jager, Philip L ^b,c   Rosand, Jonathan ^a,b   Biffi, Alessandro ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; APOE; Cerebral amyloid angiopathy; Linkage disequilibrium; TOMM40

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TOMM40 GENE; VASCULAR AMYLOIDOSIS;

EID: 84862269849     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0161-1     Document Type: Article

References (50)

1. Vinters HV, Gilbery JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke. 1983; 14: 924-8.
2. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology. 1996; 46: 1592-6.
3. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001; 344: 1450-60.
4. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010; 9: 689-701.
5. Vinters HV. Cerebral amyloid angiopathy: a microvascular link between parenchymal and vascular dementia? Ann Neurol. 2001; 49: 691-3.
6. Greenberg SM, Gurol ME, Rosand J, Smith EE. Amyloid angiopathy-related vascular cognitive impairment. Stroke. 2004; 35: 2616-9.
7. van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010; 9: 167-76.
8. O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and risk of recurrent lobar intracerebral hemorrhage. N Engl J Med. 2000; 342: 240-5.
9. Biffi A, Haplin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010; 75: 693-8.
10. Greenberg SM, Vonsattel JP. Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke. 1997; 28(7): 1418-22.
11. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology. 1996; 46: 1592-6.
12. Bekris LM, Yu CE, Bird TD, et al. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010; 23: 213-27.
13. Revesz T, Holton JL, Lashley T, et al. Genetics and molecular pathologenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol. 2009; 118: 115-30.
14. Biffi A, Sonni A, Anderson CD, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010; 68(6): 934-43.
15. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011; 43(5): 436-41.
16. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011; 43(5): 429-35.
17. Hong MG, Alexeyenko A, Lambert JC, et al. Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer's disease. J Hum Genet. 2010; 55(10): 707-9.
18. Roses AD. An inherited variable Poly-T repeat genotype in TOMM40 in Alzheimer's disease. Arch Neurol. 2010; 67(5): 536-41.
19. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011; 377(9770): 1019-31.
20. Revesz T, Ghiso J, Lashley T, et al. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol. 2003; 62(9): 885-98.
21. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 2011; 10(3): 241-52.
22. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001; 56(4): 537-9.
23. Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010; 74(3): 201-9.
24. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993; 43(11): 2412-4.
25. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3): 189-98.
26. Arvanitakis Z, Leurgans SE, Wang Z, et al. Cerebral amyloid angiopathy pathology and cognitive decline in older persons. Ann Neurol. 2011; 69: 320-7.
27. Bennett DA, Schneider JA, Buchman AS, et al. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005; 25: 163-75.
28. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 1984; 34: 939-44.
29. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 2003; 60: 246-52.
30. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997; 18(4 Suppl): S1-2.
31. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82: 239-59.
32. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (cerad). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991; 41: 479-86.
33. Olichney JM, Hansen LA, Hofstetter CR, et al. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol. 1995; 52: 702-8.
34. Nakata-Kudo Y, Mizuna T, Yamada K, et al. Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease. Dement Geriatr Cogn Disord. 2006; 22: 8-14.
35. Mandybur TI. The incidence of cerebral amyloid angiopahy in Alzheimer's disease. Neurology. 1975; 25: 120-6.
36. Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology-a pilot study. Acta Neuropathol. 2004; 107: 83-90.
37. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006; 66: 1837-44.
38. Biffi A, Shulman JM, Jagiella JM, et al. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012; 78: 1-8.
39. Biffi A, Anderson CD, Desikan RS, et al. Genetic variation and neuroimaging measures in Alzheimer's disease. Arch Neruol. 2010; 67(6): 677-85.
40. Potkin SG, Guffanti G, Lakatos A, et al. Alzheimer's Disease Neuroimaging Initiative. Hippocampal atrophy as a quantitative trait in genome-wide association study indentifying novel susceptibility genes for Alzheimer's disease. PLoS One. 2009; 4(8): e6501.
41. Purcell SM, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81(3): 559-75.
42. Breslow NE, Day NE. Statistical methods in cancer research. Volume I-the analysis of case-control studies. IARC Sci Publ. 1980; 32: 5-338.
43. Samarasekera N, Smith C, Al-Shahi Salman R. The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2012; 83: 275-81.
44. Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology. 1998; 50(4): 961-5.
45. McCarron MO, Nicoll JA, Stewart J, et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol. 1999; 58(7): 711-8.
46. Grossman I, Lutz MW, Crenshaw DG, et al. Alzheimer's disease: diagnostics, prognosis and the road to prevention. EPMA J. 2010; 1(2): 293-303.
47. Herculano-Houzel S. Scaling of brain metabolism with a fixed energy budget per neuron: implications for neuronal activity, plasticity and evolution. PLoS One. 2011; 6(3): e17514.
48. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004; 430(7000): 631-9.
49. Hansson-Petersen CA, Alikhani N, Behbahani H, et al. The amyloid β-peptide is imported into mitochondrial via the TOM import machinery and localized to mitochondrial cristae. PNAS. 2008; 105(35): 13145-50.
50. Purcell SM, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003; 19(1): 149-50.